Skip to main content
Tricuspid RegurgitationDeviceDrug

What this study is

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

What's being tested

  • Edwards PASCAL System

    Intervention · DEVICE

    Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

  • Optimal Medical Therapy

    Intervention · DRUG

    Optimal Medical Therapy alone in patients with tricuspid regurgitation

  • Edwards PASCAL System

    Intervention · DEVICE

    Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

  • Edwards PASCAL System

    Intervention · DEVICE

    Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Study details

Official title
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Sponsor
Edwards Lifesciences
Conditions
Tricuspid Regurgitation · Tricuspid Valve Insufficiency · Tricuspid Valve Disease
Enrolling
1,270 people
Starts
2019-12-11
Est. completion
2031-12-31
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗